| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_37f4922dfb7777b019e504b885211b8e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c5073a0063d6be9e25c14d2af0a1ee89
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b01dcd61775e996fac631d4b10c4e87f |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0042
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N9-0036 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-80
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N9-00 |
| filingDate |
2012-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_89efb7c158939de62931e1fd0a471a54
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a4579341e38c85b153f0e6e91323d650
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f44f7b063b81baa90cfb06966802173e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5a5f1f4f9c9c83bdd71e94ad6c6e200
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aacc73f5f8b939a33d79b7bd95ba36e0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbe75c01ca23cffeb03c54794318a246 |
| publicationDate |
2018-03-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2660156-T3 |
| titleOfInvention |
Cytochrome P450 mutant 2B6 proteins and uses thereof |
| abstract |
CYP2B6 protein comprising (i) the amino acid sequence of Figure 1 (SEQ ID No 1), or (ii) a variant or fragment of (i), wherein said variant or fragment is at least 90% identical to those residues 1-490 of Figure 1 (SEQ ID NO: 1) and comprises residues 114V, 199M and 477W, as shown in Figure 1 (SEQ ID No. 1) and said variant or fragment retains the activity of CPA hydroxylase of the protein having the full length amino acid sequence of Figure 1 (SEQ ID No 1). |
| priorityDate |
2011-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |